Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
This analysis is a follow-up to research presented by Prime/MRx in 2023, which found that 71 percent of individuals were no longer taking these drugs for weight loss at one year, representing a further 14 percent point decrease in persistence in just one year
[PMID: 7329316] PubMed record related to this compound for laboratory literature review
A.RodriguezJ.PortheaultD.LeyrolleQ.BindelsL
Mayatepek E, Nezu J, Tamai I, Oku A, Katsura M, Shimane M, Tsuji A: Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency
US$ 27.04
US$ 23.00
US$ 22.41
US$ 29.40
US$ 26.18
